Related Experiment Videos

Vascular disease risk factor management 4 years after carotid endarterectomy: are opportunities missed?

Sandy Middleton1, John Harris, Robert Lusby

  • 1Centre for Applied Nursing Research, South Western Sydney Area Health Service, Sydney, New South Wales, Australia.

ANZ Journal of Surgery
|March 29, 2003
PubMed

Insights

Vascular risk factor management after carotid endarterectomy (CEA) is suboptimal. Many patients have uncontrolled high blood pressure, cholesterol, and obesity, highlighting a need for improved post-surgery care strategies.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Medicine
  • Public Health

Background:

  • A significant proportion of patients who survive carotid endarterectomy (CEA) die from vascular causes.
  • Effective management of vascular risk factors post-CEA is crucial for long-term patient outcomes.

Purpose of the Study:

  • To assess the status of vascular risk factor management in patients several years after undergoing CEA.
  • To identify areas for improvement in post-CEA patient care and risk reduction strategies.

Main Methods:

  • A cohort of patients who underwent CEA in 1995 were surveyed using a self-administered questionnaire.
  • The questionnaire collected data on vascular risk factors including hypertension, cholesterol, smoking, physical activity, and weight.

Main Results:

  • High rates of suboptimal risk factor control were observed: 16.7% had high cholesterol, 17.3% were current smokers, and 35.2% lacked sufficient physical activity.
  • Overweight (30.2%) and obesity (14.8%) were prevalent. While most patients had a GP, adherence to medication and lifestyle recommendations appeared insufficient.
  • Only 76.5% reported taking blood-thinning medication, and recall of blood pressure control varied, with 20.8% not considering their reading appropriate.

Conclusions:

  • Vascular risk factor management following CEA is currently suboptimal.
  • There is a clear need to implement and evaluate new strategies to improve the long-term health outcomes of CEA patients.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...